申请人:Kinnate Biopharma Inc.
公开号:US20210130340A1
公开(公告)日:2021-05-06
Provided herein are inhibitors of cyclin-dependent kinases (CDKs), pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.